India's obesity drug market grows fivefold as Mounjaro and Wegovy gain traction amid rising diabetes and obesity cases.

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...